Ventus Therapeutics

Ventus Therapeutics is a biopharmaceutical company dedicated to the discovery and development of novel small-molecule drugs targeting the innate immune system for the treatment of autoimmune diseases, inflammatory conditions, and cancer. The company is exploring a unique structure-based drug discovery approach to address biologically validated but elusive drug targets. By leveraging two platforms, Ventus Therapeutics has expanded the range of targets applicable to small-molecule drugs, including previously undruggable targets as well as those with significant room for improvement over existing compounds. The team at Ventus Therapeutics consists of seasoned biopharmaceutical executives and scientists.